Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Tigecycline MeSH Descriptor Data 2026


MeSH Heading
Tigecycline
Tree Number(s)
D02.455.426.559.847.562.900.937
D04.615.562.900.937
Unique ID
D000078304
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000078304
Scope Note
A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia.
Entry Term(s)
9-(tert-Butylglycylamido)minocycline
GAR 936
GAR-936
TBG-MINO
Tygacil
Pharm Action
Anti-Bacterial Agents
Protein Synthesis Inhibitors
Registry Numbers
70JE2N95KR
0
CAS Type 1 Name
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
Public MeSH Note
2019; TIGECYCLINE was indexed under MINOCYCLINE/analogs & derivatives 1999-2018
History Note
2019 (1999)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Tigecycline Preferred
Tygacil Narrower
GAR 936 Narrower
page delivered in 0.142s